Anti-KIT designer T cells for the treatment of gastrointestinal stromal tumor
2013 · Journal of Translational Medicine · 26 citations
https://doi.org/10.1186/1479-5876-11-46
R
Rachel A. Burga
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
72
Papers
1.8K
Citations
20
h-index
22
i10-index
Rachel A. Burga is an academic researcher from Barricaid (United States). The author has contributed to research in topics: CAR-T cell therapy research & Immune Cell Function and Interaction & Immunotherapy and Immune Responses. The author has an h-index of 20, co-authored 62 publications.
ORCID: 0000-0002-0204-8986Papers by this author
worksCombination of tucatinib and neural stem cells secreting anti-HER2 antibody prolongs survival of mice with metastatic brain cancer
2021 · Proceedings of the National Academy of Sciences · 16 citations
https://doi.org/10.1073/pnas.2112491119
IL-2-independent expansion, persistence, and antitumor activity in TIL expressing regulatable membrane-bound IL-15
2025 · Molecular Therapy · 5 citations
https://doi.org/10.1016/j.ymthe.2025.04.031
Potent cytotoxic tumor-infiltrating lymphocytes can be generated from immune-excluded chondrosarcomas using regulatable membrane-bound IL15
2026 · Cancer Immunology Research · 0 citations
https://doi.org/10.1158/2326-6066.cir-25-1016
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat